Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scotia calls in administrators:

This article was originally published in Clinica

Executive Summary

The Scotia group of companies, UK developers of Foscan, a photodynamic therapy for head and neck cancers, has gone into administration. The administrator, accountancy firm Ernst & Young, is not writing off Scotia completely, however. Joint administrator Andrew Wollaston said: "Scotia has developed an impressive intellectual property portfolio with both current and future value opportunities and our immediate strategy is to explore all options in order to preserve and enhance the company's key platform technologies, including Foscan."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT069770

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel